Home/Filings/5/0001493152-21-003966
5//SEC Filing

Peitz Tristan 5

Accession 0001493152-21-003966

CIK 0001310527other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:01 PM ET

Size

8.6 KB

Accession

0001493152-21-003966

Insider Transaction Report

Form 5
Period: 2020-12-31
Transactions
  • Award

    COMMON STOCK

    2020-12-17$0.22/sh+36,364$8,00036,364 total
  • Award

    Options to Buy Common Stock

    2020-01-06+40,00040,000 total
    Exercise: $0.50From: 2020-01-06Exp: 2030-01-06COMMON STOCK (40,000 underlying)
Holdings
  • Options to Buy Common Stock

    Exercise: $0.50From: 2018-12-01Exp: 2028-06-01COMMON STOCK (32,000 underlying)
    32,000
Footnotes (1)
  • [F1]Shares acquired upon conversion of accrued directors fees at a conversion price of $0.22 per share.

Documents

1 file

Issuer

QSAM Biosciences, Inc.

CIK 0001310527

Entity typeother

Related Parties

1
  • filerCIK 0001706214

Filing Metadata

Form type
5
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:01 PM ET
Size
8.6 KB